{"id":21372,"date":"2023-11-29T14:53:28","date_gmt":"2023-11-29T13:53:28","guid":{"rendered":"https:\/\/ggba.swiss\/?p=21372"},"modified":"2023-11-29T14:53:29","modified_gmt":"2023-11-29T13:53:29","slug":"western-switzerland-medtech-start-ups-embark-on-human-trials","status":"publish","type":"post","link":"https:\/\/ggba.swiss\/en\/western-switzerland-medtech-start-ups-embark-on-human-trials\/","title":{"rendered":"Western Switzerland medtech start-ups embark on human trials"},"content":{"rendered":"\n

Companies like Compremium, Cutiss, Comphya and Novostia are currently testing their groundbreaking technologies in human trials.<\/p>\n\n\n\n

Compremium\u2019s diagnostic innovations<\/h4>\n\n\n\n

Compremium<\/a> is developing non-invasive, portable diagnostic solutions for pressure-related conditions in the human body. Utilizing ultrasound-based technology, Compremium’s pressure sensor, employing the pressure-related ultrasound \u2013 PrUS \u2013 approach, demonstrated promising results in a recent pediatric study. This technology could revolutionize the management of soft tissue swelling after limb fractures, mitigating the risk of acute compartment syndrome (ACS). Further trials are anticipated to validate its efficacy in clinical settings. The Bern-based innovator has delivered its pioneering Compartmental Compressibility Monitoring System to NASA<\/a>, a significant leap in ensuring astronaut health for deep space missions.<\/p>\n\n\n\n

Cutiss\u2019 skin regenerative advances<\/h4>\n\n\n\n

Cutiss<\/a>, specializing in skin regenerative medicine and tissue engineering based on technology developed at the CSEM<\/a> in Neuch\u00e2tel, has completed recruitment for its denovoSkin phase II trial. This study, involving Swiss, Italian, and Dutch hospitals, focuses on the safety and efficacy of denovoSkin, a personalized, bio-engineered skin substitute, in reconstructive surgery. With a 3-year follow-up period, initial results could emerge within the next year. Additionally, denovoSkin is transitioning towards phase III trials for treating burns, having received Orphan Drug Designation from various regulatory bodies.<\/p>\n\n\n\n

Comphya\u2019s erectile dysfunction treatment<\/h4>\n\n\n\n

EPFL spin-off Comphya<\/a> is addressing erectile dysfunction with its patented neuro-stimulator, CaverSTIM. Designed for patients non-responsive to oral therapy, this implanted device selectively activates the nerve to trigger penile erection. The first successful implantations have been carried out in spinal cord injury individuals in Brazil, with more surgeries underway.<\/p>\n\n\n\n

Novostia\u2019s artificial heart valve<\/h4>\n\n\n\n

Lausanne-based Novostia<\/a> is developing an artificial heart valve, TRIFLO, made from high-performance biocompatible material. This innovative valve ensures optimal blood flow and clot prevention. Novostia recently received approval for a First-in-Human trial<\/a> of its aortic heart valve prosthesis in Lithuania. The TRIFLO project has garnered support from EU and Swiss funding bodies, reflecting its potential in improving heart valve replacement therapies.<\/p>\n\n\n\n

These medical technology start-ups and innovations from Western Switzerland are at the forefront of medical innovation, with human trials set to validate their transformative technologies. Their advancements hold the promise of significantly improving patient care and outcomes in various medical fields.<\/p>\n","protected":false},"excerpt":{"rendered":"

Medtech start-ups from Western Switzerland are making significant strides in healthcare, bringing forth innovative solutions for critical medical challenges such as heart valve diseases, grave skin defects, and erectile dysfunction.<\/p>\n","protected":false},"author":6,"featured_media":21373,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"inline_featured_image":false,"mc4wp_mailchimp_campaign":[],"footnotes":""},"categories":[833],"tags":[890,963,926,902],"class_list":["post-21372","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-life-science","tag-healthcare","tag-medical-devices","tag-medtech","tag-personalized-medicine"],"acf":[],"yoast_head":"\nWestern Switzerland medtech start-ups embark on human trials<\/title>\n<meta name=\"description\" content=\"Start-ups from Western Switzerland are making strides in healthcare, bringing forth innovative solutions for critical medical challenges.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/ggba.swiss\/en\/western-switzerland-medtech-start-ups-embark-on-human-trials\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Western Switzerland medtech start-ups embark on human trials\" \/>\n<meta property=\"og:description\" content=\"Start-ups from Western Switzerland are making strides in healthcare, bringing forth innovative solutions for critical medical challenges.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/ggba.swiss\/en\/western-switzerland-medtech-start-ups-embark-on-human-trials\/\" \/>\n<meta property=\"og:site_name\" content=\"Greater Geneva Bern area\" \/>\n<meta property=\"article:published_time\" content=\"2023-11-29T13:53:28+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2023-11-29T13:53:29+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/ggba.swiss\/app\/uploads\/2023\/11\/Swiss-Medtech-1180x811-1-1024x704.jpeg\" \/>\n\t<meta property=\"og:image:width\" content=\"1024\" \/>\n\t<meta property=\"og:image:height\" content=\"704\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Pierre-Yves Oehrli\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Pierre-Yves Oehrli\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/ggba.swiss\/en\/western-switzerland-medtech-start-ups-embark-on-human-trials\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/ggba.swiss\/en\/western-switzerland-medtech-start-ups-embark-on-human-trials\/\"},\"author\":{\"name\":\"Pierre-Yves Oehrli\",\"@id\":\"https:\/\/staging.ggba.swiss\/en\/#\/schema\/person\/0b2e6d04131e3d01237dcb741fa33d41\"},\"headline\":\"Western Switzerland medtech start-ups embark on human trials\",\"datePublished\":\"2023-11-29T13:53:28+00:00\",\"dateModified\":\"2023-11-29T13:53:29+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/ggba.swiss\/en\/western-switzerland-medtech-start-ups-embark-on-human-trials\/\"},\"wordCount\":369,\"commentCount\":0,\"image\":{\"@id\":\"https:\/\/ggba.swiss\/en\/western-switzerland-medtech-start-ups-embark-on-human-trials\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/ggba.swiss\/app\/uploads\/2023\/11\/Swiss-Medtech-1180x811-1.jpeg\",\"keywords\":[\"Healthcare\",\"Medical Devices\",\"Medtech\",\"Personalized Medicine\"],\"articleSection\":[\"Life sciences\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/ggba.swiss\/en\/western-switzerland-medtech-start-ups-embark-on-human-trials\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/ggba.swiss\/en\/western-switzerland-medtech-start-ups-embark-on-human-trials\/\",\"url\":\"https:\/\/ggba.swiss\/en\/western-switzerland-medtech-start-ups-embark-on-human-trials\/\",\"name\":\"Western Switzerland medtech start-ups embark on human trials\",\"isPartOf\":{\"@id\":\"https:\/\/staging.ggba.swiss\/en\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/ggba.swiss\/en\/western-switzerland-medtech-start-ups-embark-on-human-trials\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/ggba.swiss\/en\/western-switzerland-medtech-start-ups-embark-on-human-trials\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/ggba.swiss\/app\/uploads\/2023\/11\/Swiss-Medtech-1180x811-1.jpeg\",\"datePublished\":\"2023-11-29T13:53:28+00:00\",\"dateModified\":\"2023-11-29T13:53:29+00:00\",\"author\":{\"@id\":\"https:\/\/staging.ggba.swiss\/en\/#\/schema\/person\/0b2e6d04131e3d01237dcb741fa33d41\"},\"description\":\"Start-ups from Western Switzerland are making strides in healthcare, bringing forth innovative solutions for critical medical challenges.\",\"breadcrumb\":{\"@id\":\"https:\/\/ggba.swiss\/en\/western-switzerland-medtech-start-ups-embark-on-human-trials\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/ggba.swiss\/en\/western-switzerland-medtech-start-ups-embark-on-human-trials\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/ggba.swiss\/en\/western-switzerland-medtech-start-ups-embark-on-human-trials\/#primaryimage\",\"url\":\"https:\/\/ggba.swiss\/app\/uploads\/2023\/11\/Swiss-Medtech-1180x811-1.jpeg\",\"contentUrl\":\"https:\/\/ggba.swiss\/app\/uploads\/2023\/11\/Swiss-Medtech-1180x811-1.jpeg\",\"width\":2360,\"height\":1622,\"caption\":\"Medtech start-ups from Western Switzerland are making significant strides in healthcare, bringing forth innovative solutions for critical medical challenges such as heart valve diseases, grave skin defects, and erectile dysfunction.\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/ggba.swiss\/en\/western-switzerland-medtech-start-ups-embark-on-human-trials\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/ggba.swiss\/en\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Western Switzerland medtech start-ups embark on human trials\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/staging.ggba.swiss\/en\/#website\",\"url\":\"https:\/\/staging.ggba.swiss\/en\/\",\"name\":\"Greater Geneva Bern area\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/staging.ggba.swiss\/en\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/staging.ggba.swiss\/en\/#\/schema\/person\/0b2e6d04131e3d01237dcb741fa33d41\",\"name\":\"Pierre-Yves Oehrli\",\"url\":\"https:\/\/ggba.swiss\/en\/author\/pierre-yves-oehrli\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Western Switzerland medtech start-ups embark on human trials","description":"Start-ups from Western Switzerland are making strides in healthcare, bringing forth innovative solutions for critical medical challenges.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/ggba.swiss\/en\/western-switzerland-medtech-start-ups-embark-on-human-trials\/","og_locale":"en_US","og_type":"article","og_title":"Western Switzerland medtech start-ups embark on human trials","og_description":"Start-ups from Western Switzerland are making strides in healthcare, bringing forth innovative solutions for critical medical challenges.","og_url":"https:\/\/ggba.swiss\/en\/western-switzerland-medtech-start-ups-embark-on-human-trials\/","og_site_name":"Greater Geneva Bern area","article_published_time":"2023-11-29T13:53:28+00:00","article_modified_time":"2023-11-29T13:53:29+00:00","og_image":[{"width":1024,"height":704,"url":"https:\/\/ggba.swiss\/app\/uploads\/2023\/11\/Swiss-Medtech-1180x811-1-1024x704.jpeg","type":"image\/jpeg"}],"author":"Pierre-Yves Oehrli","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Pierre-Yves Oehrli","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/ggba.swiss\/en\/western-switzerland-medtech-start-ups-embark-on-human-trials\/#article","isPartOf":{"@id":"https:\/\/ggba.swiss\/en\/western-switzerland-medtech-start-ups-embark-on-human-trials\/"},"author":{"name":"Pierre-Yves Oehrli","@id":"https:\/\/staging.ggba.swiss\/en\/#\/schema\/person\/0b2e6d04131e3d01237dcb741fa33d41"},"headline":"Western Switzerland medtech start-ups embark on human trials","datePublished":"2023-11-29T13:53:28+00:00","dateModified":"2023-11-29T13:53:29+00:00","mainEntityOfPage":{"@id":"https:\/\/ggba.swiss\/en\/western-switzerland-medtech-start-ups-embark-on-human-trials\/"},"wordCount":369,"commentCount":0,"image":{"@id":"https:\/\/ggba.swiss\/en\/western-switzerland-medtech-start-ups-embark-on-human-trials\/#primaryimage"},"thumbnailUrl":"https:\/\/ggba.swiss\/app\/uploads\/2023\/11\/Swiss-Medtech-1180x811-1.jpeg","keywords":["Healthcare","Medical Devices","Medtech","Personalized Medicine"],"articleSection":["Life sciences"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/ggba.swiss\/en\/western-switzerland-medtech-start-ups-embark-on-human-trials\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/ggba.swiss\/en\/western-switzerland-medtech-start-ups-embark-on-human-trials\/","url":"https:\/\/ggba.swiss\/en\/western-switzerland-medtech-start-ups-embark-on-human-trials\/","name":"Western Switzerland medtech start-ups embark on human trials","isPartOf":{"@id":"https:\/\/staging.ggba.swiss\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/ggba.swiss\/en\/western-switzerland-medtech-start-ups-embark-on-human-trials\/#primaryimage"},"image":{"@id":"https:\/\/ggba.swiss\/en\/western-switzerland-medtech-start-ups-embark-on-human-trials\/#primaryimage"},"thumbnailUrl":"https:\/\/ggba.swiss\/app\/uploads\/2023\/11\/Swiss-Medtech-1180x811-1.jpeg","datePublished":"2023-11-29T13:53:28+00:00","dateModified":"2023-11-29T13:53:29+00:00","author":{"@id":"https:\/\/staging.ggba.swiss\/en\/#\/schema\/person\/0b2e6d04131e3d01237dcb741fa33d41"},"description":"Start-ups from Western Switzerland are making strides in healthcare, bringing forth innovative solutions for critical medical challenges.","breadcrumb":{"@id":"https:\/\/ggba.swiss\/en\/western-switzerland-medtech-start-ups-embark-on-human-trials\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/ggba.swiss\/en\/western-switzerland-medtech-start-ups-embark-on-human-trials\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/ggba.swiss\/en\/western-switzerland-medtech-start-ups-embark-on-human-trials\/#primaryimage","url":"https:\/\/ggba.swiss\/app\/uploads\/2023\/11\/Swiss-Medtech-1180x811-1.jpeg","contentUrl":"https:\/\/ggba.swiss\/app\/uploads\/2023\/11\/Swiss-Medtech-1180x811-1.jpeg","width":2360,"height":1622,"caption":"Medtech start-ups from Western Switzerland are making significant strides in healthcare, bringing forth innovative solutions for critical medical challenges such as heart valve diseases, grave skin defects, and erectile dysfunction."},{"@type":"BreadcrumbList","@id":"https:\/\/ggba.swiss\/en\/western-switzerland-medtech-start-ups-embark-on-human-trials\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/ggba.swiss\/en\/"},{"@type":"ListItem","position":2,"name":"Western Switzerland medtech start-ups embark on human trials"}]},{"@type":"WebSite","@id":"https:\/\/staging.ggba.swiss\/en\/#website","url":"https:\/\/staging.ggba.swiss\/en\/","name":"Greater Geneva Bern area","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/staging.ggba.swiss\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/staging.ggba.swiss\/en\/#\/schema\/person\/0b2e6d04131e3d01237dcb741fa33d41","name":"Pierre-Yves Oehrli","url":"https:\/\/ggba.swiss\/en\/author\/pierre-yves-oehrli\/"}]}},"_links":{"self":[{"href":"https:\/\/ggba.swiss\/en\/wp-json\/wp\/v2\/posts\/21372","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/ggba.swiss\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/ggba.swiss\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/ggba.swiss\/en\/wp-json\/wp\/v2\/users\/6"}],"replies":[{"embeddable":true,"href":"https:\/\/ggba.swiss\/en\/wp-json\/wp\/v2\/comments?post=21372"}],"version-history":[{"count":2,"href":"https:\/\/ggba.swiss\/en\/wp-json\/wp\/v2\/posts\/21372\/revisions"}],"predecessor-version":[{"id":21377,"href":"https:\/\/ggba.swiss\/en\/wp-json\/wp\/v2\/posts\/21372\/revisions\/21377"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/ggba.swiss\/en\/wp-json\/wp\/v2\/media\/21373"}],"wp:attachment":[{"href":"https:\/\/ggba.swiss\/en\/wp-json\/wp\/v2\/media?parent=21372"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/ggba.swiss\/en\/wp-json\/wp\/v2\/categories?post=21372"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/ggba.swiss\/en\/wp-json\/wp\/v2\/tags?post=21372"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}